Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously
Shyld AI
May 14, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
GenieRx has completed the acquisition of Omnicare, a pharmacy business in the long-term care segment in the United States, for $250 million. Omnicare supplies long-term care pharmacy services to patients and facilities, and CVS is divesting the unit as part of its pharmacy portfolio restructuring. GenieRx acquisitions in healthcare M&A focus on stabilizing and operating pharmacy dispensing for senior and institutional customers, supporting a divestiture acquisition strategy. The announced divestiture acquisition is structured as a private equity acquisition, with closing cash consideration of $250 million and an expected transition following court approval.
Filed under
Source
Read full article on beckershospitalreview.comvia Becker's Hospital Review — All · May 14, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Shyld AI
May 14, 2026
Amarox→CEL-SCI
May 14, 2026
Create Medicines
May 14, 2026
Zydus Worldwide DMCC→Assertio Holdings
May 14, 2026
Biogen→Apellis Pharmaceuticals
May 14, 2026